Takeda Pharmaceutical Company Limited
TKPHF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $108 | $144 | $317 | $230 |
| Dep. & Amort. | $761 | $728 | $664 | $583 |
| Deferred Tax | $67 | -$91 | $58 | $72 |
| Stock-Based Comp. | $73 | $71 | $61 | $43 |
| Change in WC | -$59 | -$256 | -$25 | $99 |
| Other Non-Cash | $107 | $121 | -$98 | $95 |
| Operating Cash Flow | $1,057 | $716 | $977 | $1,123 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$201 | -$175 | -$634 | -$186 |
| Net Acquisitions | $77 | $0 | $8 | -$21 |
| Inv. Purchases | -$111 | -$40 | -$10 | -$8 |
| Inv. Sales/Matur. | $29 | $8 | $22 | $17 |
| Other Inv. Act. | -$162 | -$256 | $7 | $1 |
| Investing Cash Flow | -$367 | -$464 | -$607 | -$198 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$314 | $2 | -$325 | -$600 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$52 | -$2 | -$27 | -$78 |
| Dividends Paid | -$302 | -$287 | -$279 | -$284 |
| Other Fin. Act. | -$83 | -$66 | -$78 | -$109 |
| Financing Cash Flow | -$751 | -$354 | -$709 | -$1,070 |
| Forex Effect | -$11 | $26 | $23 | $29 |
| Net Chg. in Cash | -$73 | -$76 | -$316 | -$117 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $458 | $534 | $850 | $966 |
| End Cash | $385 | $458 | $534 | $850 |
| Free Cash Flow | $678 | $236 | $343 | $937 |